The placement is a result of the successful Hong Kong, Sydney and Melbourne investor briefing with regards to the Company’s recent Appendix 4C results.

During the briefing roadshow, both existing and new institutional investors indicated a strong desire to participate in any future capital raisings the company planned. Such was the demand, that the placement price is at a premium to the current market 5 day Volume Weighted Average Price (VWAP) price up to the 31st October, with a total of up to 34,210,526 new shares to be issued.

The ‘at market’ price of 19c has been calculated based upon a 5 day Volume Weighted Average of $18.846c.

The placement includes the issue of unlisted options, distributed pro-rata to participants, and issued at a ratcheting strike price of
• $0.24 on a 1 to 12 basis, based upon 15 month expiry, or up to 2,850,877 options. • $0.27 on a 1 to 12 basis, based upon 18 month expiry, or up to 2,850,877 options. • $0.31 on a 1 to 12 basis, based upon 27 month expiry, or up to 2,850,877 options.
Full exercise of the above options would provide the Company with up to an additional $2.33m in working capital.

The capital will be applied towards “own funds” requirements for its EEA authorised payment subsidiary, iSignthis eMoney Ltd (SWIFT BIC : ISEMCY21) trading as ISXPay®, and also in accelerating the Company’s strategy further by expanding sales and marketing activity.
The Company requests that the trading halt be lifted, and that normal trading commence.

*An Appendix 3B and Section 708(5) cleansing statement will follow next week based on finalisation of settlement figures.